BioCentury

7:00 AM GMT, Jul 16, 2012
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Emerging Company Profile

PeptiVir: Universal stabilization

Current peptide stabilization technologies use chemical linkers to keep peptides in their natural state, but in some cases these can cause autoimmune reactions. PeptiVir Inc. aims to avoid such effects by placing hydrophobic amino acids in specific locations within the core of its synthetic peptides to stabilize the compounds.

In the body, peptides are connected to other proteins that act as a stabilizing scaffold to maintain the peptide in a biologically active alpha helix conformation. The alpha helix regions allow the peptides to interact with

Read the full 845 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.